BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Leukocyte
,
Metabolism of nitric oxide
,
Rosiglitazone
,
rs3825942
,
PTEN
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TIAM1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cerebellum
Cerebellar hemisphere
Cerebellar vermis
Cerebellum peduncles
Thalamus lateral nuclei
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Epilepsy
Esophageal cancer
Pyloric ulcer
Cytomegalovirus infection
Meningitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Zalypsis
carbetapentane
myrtecaine
Lidocaine
Antibodies, Anti-DNA
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SHANK3
SETD6
RRS1
PICALM
BCOR
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progress…
Identification of TIAM1 as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellu…
Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability,…
Upregulation of miR-22 alleviates oxygen-glucose deprivation/reperfusion-induced injury by targeting…
ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cance…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ